Molecular Oncology

Targeted Solid Tumor Panels
HOPESEQ GI/GYN/GU HopeSeq Solid Tumors Assay, Microsatellite Instability Analysis by PCR (MSI)
HOPESEQ GLIOMA HopeSeq Solid Tumors Assay, MSI, MGMT Methylation Analysis by PCR, PD-L1 IHC
HOPESEQ LUNG TUMORS HopeSeq Solid Tumors Assay, MSI and PD-L1 Immunohistochemistry (IHC)
HOPESEQ MELANOMA HopeSeq Solid Tumors Assay, MSI and PD-L1 Immunohistochemistry (IHC)
HOPESEQ THYROID HopeSeq Solid Tumors Assay, MSI
HOPESEQ THYROID, FNA HopeSeq Solid Tumors Assay
HOPESEQ BREAST HopeSeq Solid Tumors Assay, MSI, PD-L1 IHC
HOPESEQ SARCOMA HopeSeq Solid Tumors Assay, HopeSeq Fusions, MSI
HOPESEQ FUSIONS RNAseq NGS Assay
HOPESEQ SOLID TUMOR COMPLETE HopeSeq Solid Tumors Assay, MSI and PD-L1 Immunohistochemistry (IHC)
 
Individual Molecular Oncology Testing for Solid Tumors
  • IDH1/IDH2 mutations
  • MET exon 14 mutations
  • MGMT promoter methylation analysis by PCR
  • Microsatellite Instability Analysis (MSI) by PCR
  • MLH1 methylation
  • TERT promoter mutation analysis
  • PD-L1 immunostain